Literature DB >> 17285297

Adenosine protects against suicidal erythrocyte death.

Olivier M Niemoeller1, Peter J Bentzen, Elisabeth Lang, Florian Lang.   

Abstract

Suicidal death of erythrocytes or eryptosis is characterized by cell shrinkage and cell membrane scrambling leading to phosphatidylserine exposure at the erythrocyte surface. The cell membrane scrambling is triggered by an increase in cytosolic Ca(2+) activity and activation of protein kinase C (PKC). Phosphatidylserine exposure fosters adherence of affected erythrocytes to the vascular wall. Thus, microcirculation in ischemic tissues may be impaired by the appearance of eryptotic erythrocytes. Ischemia leads to release of adenosine, which in most tissues leads to vasodilation and protects against cell injury. The present experiments explored whether adenosine influences mechanisms underlying eryptosis. Erythrocyte phosphatidylserine exposure was estimated from annexin V binding, cell volume from forward scatter and cytosolic Ca(2+) activity from Fluo3 fluorescence. Glucose depletion (for 24 or 48 h) significantly increased annexin binding and decreased forward scatter, effects partially reversed by adenosine. The protective effect of adenosine reached statistical significance (s.d.) at > =30 microM. Low Cl(-) solution (Cl(-) exchanged by gluconate for 24 h) similarly increased annexin binding and decreased forward scatter, effects again reversed by adenosine (s.d. at > or =10 and 30 microM, respectively). Similarly, phosphatase inhibitor okadaic acid (OA, 1 microM) and PKC activator phorbol 12-myristate-13-acetate (PMA, 3 microM) significantly enhanced annexin binding and decreased forward scatter. Adenosine significantly blunted the effects of OA and PMA on annexin V binding (s.d. at > or =30 and 10 microM, respectively) and the effect of OA on forward scatter (s.d. at > or =10 microM). In conclusion, adenosine inhibits eryptosis by a mechanism presumably effective downstream of PKC. The effect may participate in the maintenance of microcirculation in ischemic tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285297     DOI: 10.1007/s00424-007-0218-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   4.458


  95 in total

Review 1.  Discovery and prospect of protein kinase C research: epilogue.

Authors:  Yasutomi Nishizuka
Journal:  J Biochem       Date:  2003-02       Impact factor: 3.387

2.  Prevention of cycloheximide-induced apoptosis in hepatocytes by adenosine and by caspase inhibitors.

Authors:  W M Blom; H J de Bont; I Meijerman; G J Mulder; J F Nagelkerke
Journal:  Biochem Pharmacol       Date:  1999-12-15       Impact factor: 5.858

Review 3.  Mechanisms of suicidal erythrocyte death.

Authors:  Karl S Lang; Philipp A Lang; Christian Bauer; Christophe Duranton; Thomas Wieder; Stephan M Huber; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2005

4.  Enhanced programmed cell death of iron-deficient erythrocytes.

Authors:  Daniela S Kempe; Philipp A Lang; Christophe Duranton; Ahmad Akel; Karl S Lang; Stephan M Huber; Thomas Wieder; Florian Lang
Journal:  FASEB J       Date:  2005-12-21       Impact factor: 5.191

5.  Protein kinase C isoforms in human erythrocytes.

Authors:  R B Govekar; S M Zingde
Journal:  Ann Hematol       Date:  2001-09       Impact factor: 3.673

6.  Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts.

Authors:  L A Woon; J W Holland; E P Kable; B D Roufogalis
Journal:  Cell Calcium       Date:  1999-04       Impact factor: 6.817

7.  Suicidal erythrocyte death in sepsis.

Authors:  Daniela S Kempe; Ahmad Akel; Philipp A Lang; Tobias Hermle; Raja Biswas; Juliana Muresanu; Björn Friedrich; Peter Dreischer; Christiane Wolz; Ulrike Schumacher; Andreas Peschel; Friedrich Götz; Gerd Döring; Thomas Wieder; Erich Gulbins; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2006-12-16       Impact factor: 4.599

8.  A novel irreversible antagonist of the A1-adenosine receptor.

Authors:  M Srinivas; J C Shryock; P J Scammells; J Ruble; S P Baker; L Belardinelli
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

9.  A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity.

Authors:  Sara E Regan; Michael Broad; Anne M Byford; Amy R Lankford; Rachael J Cerniway; Marty W Mayo; G Paul Matherne
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-03       Impact factor: 4.733

10.  Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.

Authors:  Long T Wen; Aileen F Knowles
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

View more
  6 in total

1.  Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes.

Authors:  Richard L Sabina; Nancy J Wandersee; Cheryl A Hillery
Journal:  Br J Haematol       Date:  2008-11-19       Impact factor: 6.998

Review 2.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

Review 3.  Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.

Authors:  Elisabeth Lang; Florian Lang
Journal:  Biomed Res Int       Date:  2015-03-04       Impact factor: 3.411

Review 4.  Eryptosis: An Erythrocyte's Suicidal Type of Cell Death.

Authors:  Lisa Repsold; Anna Margaretha Joubert
Journal:  Biomed Res Int       Date:  2018-01-03       Impact factor: 3.411

Review 5.  Role of Eryptosis in Hemorrhagic Stroke.

Authors:  Mei Fang; Fan Xia; Yuqi Chen; Yuke Shen; Lu Ma; Chao You; Chuanyuan Tao; Xin Hu
Journal:  Front Mol Neurosci       Date:  2022-07-28       Impact factor: 6.261

Review 6.  Metabolic Influences Modulating Erythrocyte Deformability and Eryptosis.

Authors:  Jean-Frédéric Brun; Emmanuelle Varlet-Marie; Justine Myzia; Eric Raynaud de Mauverger; Etheresia Pretorius
Journal:  Metabolites       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.